Enovix (ENVX) Financials

$6.88 +0.13 (+1.93%)

Closing price 04:00 PM Eastern

Extended Trading

$6.90 +0.03 (+0.36%)

As of 08:00 PM Eastern

Annual Income Statements for Enovix

This table shows Enovix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	1/2/2022	1/1/2023	12/31/2023	12/29/2024	12/28/2025
Net Income / (Loss) Attributable to Common Shareholders	-40	-126	-52	-214	-222	-157
Consolidated Net Income / (Loss)	-40	-126	-52	-214	-223	-157
Net Income / (Loss) Continuing Operations	-40	-126	-52	-214	-223	-157
Total Pre-Tax Income	-40	-126	-52	-215	-224	-158
Total Operating Income	-24	-70	-132	-230	-243	-177
Total Gross Profit	-3.38	-1.97	-17	-55	-2.05	6.11
Total Revenue	0.00	0.00	6.20	7.64	23	32
Operating Revenue	0.00	0.00	6.20	7.64	23	32
Total Cost of Revenue	3.38	1.97	23	63	25	26
Operating Cost of Revenue	3.38	1.97	23	63	25	26
Total Operating Expenses	20	68	115	175	241	183
Selling, General & Admin Expense	5.71	30	52	79	74	73
Research & Development Expense	14	38	58	88	125	110
Impairment Charge	0.00	0.00	4.92	4.41	0.00	0.00
Restructuring Charge	-	0.00	0.00	3.02	42	0.00
Total Other Income / (Expense), net	-16	-56	80	15	19	19
Interest Expense	0.11	0.19	-	4.46	6.79	22
Interest & Investment Income	-	0.04	5.23	14	12	13
Other Income / (Expense), net	-16	-56	75	5.88	13	28
Income Tax Expense	-	0.00	0.00	-0.63	-1.39	-1.31
Net Income / (Loss) Attributable to Noncontrolling Interest	-	0.00	0.00	-0.06	-0.29	0.13
Basic Earnings per Share	($0.49)	($1.07)	($0.34)	($1.27)	($1.19)	($0.75)
Weighted Average Basic Shares Outstanding	80.37M	117.22M	152.92M	169.06M	186.04M	207.64M
Diluted Earnings per Share	($0.49)	($1.07)	($0.82)	($1.30)	($1.19)	($0.75)
Weighted Average Diluted Shares Outstanding	80.37M	117.22M	154.15M	169.57M	186.04M	207.64M
Weighted Average Basic & Diluted Shares Outstanding	80.37M	117.22M	157.78M	168.50M	191.27M	217.22M

This table shows Enovix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025	6/29/2025	9/28/2025	12/28/2025
Net Income / (Loss) Attributable to Common Shareholders	-64	-16	-60	-46	-116	-23	-37	-24	-45	-54	-35
Consolidated Net Income / (Loss)	-64	-16	-60	-46	-116	-23	-37	-24	-44	-54	-35
Net Income / (Loss) Continuing Operations	-64	-16	-60	-46	-116	-19	-37	-24	-44	-54	-35
Total Pre-Tax Income	-64	-16	-61	-47	-121	-20	-36	-24	-45	-54	-35
Total Operating Income	-52	-50	-65	-70	-89	-49	-35	-43	-44	-47	-44
Total Gross Profit	-14	-17	-12	-1.80	-0.66	-0.64	1.05	0.26	1.94	1.40	2.50
Total Revenue	0.04	0.20	7.38	5.27	3.77	4.32	9.72	5.10	7.47	7.99	11
Operating Revenue	0.04	0.20	7.38	5.27	3.77	4.32	9.72	5.10	7.47	7.99	11
Total Cost of Revenue	14	17	20	7.07	4.42	4.96	8.67	4.84	5.53	6.59	8.76
Operating Cost of Revenue	14	17	20	7.07	4.42	4.96	8.67	4.84	5.53	6.59	8.76
Total Operating Expenses	38	34	52	68	88	45	36	43	46	48	46
Selling, General & Admin Expense	17	17	18	20	21	21	13	17	18	20	18
Research & Development Expense	17	14	35	49	29	24	22	26	28	28	28
Total Other Income / (Expense), net	-12	34	4.11	23	-32	29	-1.78	19	-1.39	-7.22	9.08
Interest Expense	1.27	1.56	1.63	1.66	1.69	1.72	1.72	1.72	1.71	12	6.41
Interest & Investment Income	3.15	4.33	4.13	3.56	3.33	2.86	2.59	2.43	2.43	2.54	5.60
Other Income / (Expense), net	-14	31	1.61	22	-33	28	-2.65	18	-2.12	2.01	9.89
Income Tax Expense	0.00	0.00	-0.63	-0.15	-4.59	2.19	1.15	-0.16	-0.86	-0.42	0.13
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	-0.06	-0.13	-0.08	-0.10	0.01	-0.02	0.26	-0.06	-0.05
Basic Earnings per Share	($0.41)	($0.10)	($0.37)	($0.28)	($0.63)	($0.12)	($0.19)	($0.12)	($0.22)	($0.26)	($0.15)
Weighted Average Basic Shares Outstanding	157.15M	159.83M	159.07M	168.14M	183.26M	187.79M	175.04M	191.30M	204.82M	206.46M	207.64M
Diluted Earnings per Share	($0.41)	($0.29)	($0.21)	($0.28)	($0.63)	($0.28)	($0.02)	($0.12)	($0.22)	($0.27)	($0.14)
Weighted Average Diluted Shares Outstanding	157.15M	161.37M	159.58M	168.14M	183.26M	187.98M	175.04M	191.30M	204.82M	206.81M	207.64M
Weighted Average Basic & Diluted Shares Outstanding	320.25M	167.77M	168.50M	170.00M	176.28M	177.98M	191.27M	192.00M	196.60M	215.82M	217.22M

This table details how cash moves in and out of Enovix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	1/2/2022	1/1/2023	12/31/2023	12/29/2024	12/28/2025
Net Change in Cash & Equivalents	19	356	-62	-88	40	-167
Net Cash From Operating Activities	-20	-51	-83	-105	-109	-95
Net Cash From Continuing Operating Activities	-20	-51	-83	-105	-109	-95
Net Income / (Loss) Continuing Operations	-40	-126	-52	-214	-223	-157
Consolidated Net Income / (Loss)	-40	-126	-52	-214	-223	-157
Depreciation Expense	0.58	1.52	7.97	34	45	35
Amortization Expense	0.00	-	-	0.00	0.00	9.22
Non-Cash Adjustments To Reconcile Net Income	17	67	-40	68	85	23
Changes in Operating Assets and Liabilities, net	2.19	6.14	0.80	7.10	-16	-6.50
Net Cash From Investing Activities	-27	-44	-36	-143	-1.38	-538
Net Cash From Continuing Investing Activities	-27	-44	-36	-143	-1.38	-538
Purchase of Property, Plant & Equipment	-27	-44	-36	-62	-76	-18
Acquisitions	-	0.00	0.00	-9.97	0.00	-10
Purchase of Investments	-	0.00	0.00	-138	-32	-585
Sale and/or Maturity of Investments	-	0.00	0.00	67	107	75
Net Cash From Financing Activities	66	451	57	160	151	467
Net Cash From Continuing Financing Activities	66	451	57	160	151	467
Repayment of Debt	0.00	-15	0.00	-5.99	-0.21	-12
Repurchase of Common Equity	0.00	-0.03	-0.01	-0.03	-0.00	-65
Issuance of Debt	1.63	15	0.00	173	4.57	360
Issuance of Common Equity	0.00	0.00	1.90	2.35	109	1.32
Other Financing Activities, net	0.36	483	55	-9.25	38	184
Effect of Exchange Rate Changes	-	0.00	0.00	0.15	-1.17	-0.54
Cash Interest Paid	-	0.00	0.00	2.76	5.69	5.67
Cash Income Taxes Paid	-	-	0.00	0.00	0.19	1.13

This table details how cash moves in and out of Enovix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025	6/29/2025	9/28/2025	12/28/2025
Net Change in Cash & Equivalents	49	-72	-36	-11	13	-34	72	-83	-54	199	-230
Net Cash From Operating Activities	-24	-28	-27	-35	-27	-31	-16	-17	-26	-26	-27
Net Cash From Continuing Operating Activities	-24	-28	-27	-35	-27	-31	-16	-17	-26	-26	-27
Net Income / (Loss) Continuing Operations	-64	-16	-60	-46	-116	-23	-37	-24	-44	-54	-35
Consolidated Net Income / (Loss)	-64	-16	-60	-46	-116	-23	-37	-24	-44	-54	-35
Depreciation Expense	3.50	2.90	24	25	5.94	6.50	7.54	8.45	8.83	9.40	8.44
Non-Cash Adjustments To Reconcile Net Income	34	-18	10	-8.19	88	-9.92	16	-3.30	16	19	-8.48
Changes in Operating Assets and Liabilities, net	3.46	2.73	-1.48	-5.33	-4.75	-4.62	-1.66	1.48	-6.59	-0.25	-1.13
Net Cash From Investing Activities	-78	-51	-11	19	0.41	-4.53	-16	-64	-27	-248	-199
Net Cash From Continuing Investing Activities	-78	-51	-11	19	0.41	-4.53	-16	-64	-27	-248	-199
Purchase of Property, Plant & Equipment	-13	-17	-29	-15	-25	-20	-16	-6.27	-7.97	-2.97	-1.01
Purchase of Investments	-66	-50	-23	-17	-15	-	-	-58	-27	-285	-215
Sale and/or Maturity of Investments	-	17	50	51	40	15	-	0.00	19	40	17
Net Cash From Financing Activities	151	6.47	2.20	5.43	40	-0.86	107	-1.49	-1.19	473	-3.35
Net Cash From Continuing Financing Activities	151	6.47	2.20	5.43	40	-0.86	107	-1.49	-1.19	473	-3.35
Repayment of Debt	-	-0.02	-0.74	-	-	-0.11	-0.03	-	-	-9.88	-1.40
Repurchase of Common Equity	-0.00	-0.01	-0.00	-	-0.00	-0.00	-	-	-	-64	-1.08
Issuance of Common Equity	-	-	1.18	-	-	-	108	-	-	-	0.61
Other Financing Activities, net	-17	6.50	1.75	3.63	36	-0.75	-0.99	-0.98	-1.09	187	-1.48
Effect of Exchange Rate Changes	-	-	0.15	-0.54	-0.21	2.05	-2.47	-0.23	0.13	-0.31	-0.13
Cash Interest Paid	-	-	2.76	0.02	2.75	0.18	2.74	0.13	2.84	-	2.70
Cash Income Taxes Paid	-	-	-	0.09	0.06	0.02	0.02	0.04	0.15	0.88	0.06

This table presents Enovix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	1/2/2022	1/1/2023	12/31/2023	12/29/2024	12/28/2025
Total Assets	65	483	441	564	527	879
Total Current Assets	33	398	330	323	295	542
Cash & Equivalents	29	385	323	233	273	106
Short-Term Investments	-	-	0.00	74	0.00	406
Note & Lease Receivable	-	-	0.00	1.51	0.00	4.01
Accounts Receivable	-	0.00	0.17	0.91	4.57	4.42
Inventories, net	-	0.00	0.63	8.74	7.66	14
Prepaid Expenses	0.95	8.27	5.99	5.20	9.90	8.12
Plant, Property, & Equipment, net	31	77	104	166	168	170
Total Noncurrent Assets	0.63	7.83	7.07	75	64	167
Long-Term Investments	-	-	-	-	0.00	107
Goodwill	-	-	0.00	12	12	12
Intangible Assets	-	-	0.00	42	36	32
Other Noncurrent Operating Assets	0.63	7.83	7.07	20	16	16
Total Liabilities & Shareholders' Equity	65	483	441	564	527	879
Total Liabilities	29	156	84	303	278	605
Total Current Liabilities	11	21	23	61	54	65
Short-Term Debt	-	-	0.00	5.92	9.45	9.87
Accounts Payable	2.08	3.14	7.08	21	9.49	18
Accrued Expenses	2.00	7.11	7.09	14	20	14
Current Deferred Revenue	5.41	5.58	0.05	6.71	3.65	5.02
Current Employee Benefit Liabilities	1.27	4.10	8.10	11	8.23	6.22
Other Current Liabilities	0.11	0.71	0.72	2.44	3.04	12
Total Noncurrent Liabilities	18	136	61	242	224	540
Long-Term Debt	-	-	0.00	169	170	519
Noncurrent Deferred Revenue	1.65	2.29	3.72	3.77	3.77	0.30
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	0.00	11	8.78	9.12
Other Noncurrent Operating Liabilities	16	134	57	59	42	11
Total Equity & Noncontrolling Interests	36	326	356	261	249	274
Total Preferred & Common Equity	36	326	356	258	247	271
Total Common Equity	36	326	356	258	247	271
Common Stock	243	659	741	857	1,068	1,308
Retained Earnings	-207	-333	-385	-599	-821	-978
Treasury Stock	-	-	-	-	0.00	-58
Accumulated Other Comprehensive Income / (Loss)	-	-	0.00	-0.06	-0.14	-0.51
Other Equity Adjustments	-	-	0.00	-	-	0.00
Noncontrolling Interest	-	-	0.00	2.96	2.66	2.80

This table presents Enovix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2022	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	7/3/2022	10/2/2022	4/2/2023	7/2/2023	10/1/2023	3/31/2024	6/30/2024	9/29/2024	3/30/2025	6/29/2025	9/28/2025
Total Assets	487	468	411	539	520	509	489	448	499	469	914
Total Current Assets	389	356	301	414	376	278	270	224	270	228	589
Cash & Equivalents	385	349	294	343	271	222	235	201	190	136	336
Short-Term Investments	-	-	-	66	101	40	15	0.00	58	67	223
Note & Lease Receivable	-	-	-	-	-	0.14	0.00	0.00	1.26	1.11	2.41
Accounts Receivable	0.10	0.01	0.02	0.04	0.00	1.73	1.67	1.91	2.90	4.24	4.63
Inventories, net	0.67	0.45	0.82	0.80	0.22	6.54	9.51	9.56	10	13	15
Prepaid Expenses	2.03	4.51	5.86	2.93	4.18	7.21	8.84	12	7.38	6.19	7.55
Plant, Property, & Equipment, net	91	104	102	118	137	159	151	158	166	178	175
Total Noncurrent Assets	7.46	8.06	7.09	6.88	7.49	72	68	66	63	63	150
Long-Term Investments	-	-	-	-	-	-	-	-	-	-	89
Goodwill	-	-	-	-	-	12	12	12	12	12	12
Intangible Assets	-	-	-	-	-	40	39	38	35	34	33
Other Noncurrent Operating Assets	7.46	8.06	7.09	6.88	7.49	20	17	17	16	17	16
Total Liabilities & Shareholders' Equity	487	468	411	539	520	509	489	448	499	469	914
Total Liabilities	59	109	98	292	267	277	316	278	261	262	617
Total Current Liabilities	17	18	25	37	44	57	68	59	58	52	61
Short-Term Debt	-	-	-	-	-	8.49	11	12	10	10	10
Accounts Payable	6.13	6.82	4.75	13	18	19	19	15	21	14	21
Accrued Expenses	3.36	2.48	8.69	13	16	12	17	14	8.54	6.22	8.93
Current Deferred Revenue	0.28	1.37	0.35	0.35	0.00	5.31	7.01	6.21	6.63	8.07	7.69
Current Employee Benefit Liabilities	6.58	6.17	10	10	9.13	9.28	8.86	8.04	6.48	8.30	7.21
Other Current Liabilities	0.72	0.70	0.92	0.94	0.94	2.86	5.09	4.76	5.16	5.37	5.28
Total Noncurrent Liabilities	41	92	73	254	223	220	248	218	203	210	556
Long-Term Debt	-	-	-	167	167	168	169	169	169	169	518
Noncurrent Deferred Revenue	2.59	2.96	3.42	3.42	3.77	3.77	3.77	3.77	0.30	0.30	0.30
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	-	11	6.12	8.18	8.75	9.78	9.33
Other Noncurrent Operating Liabilities	39	89	70	84	52	37	70	38	25	31	28
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	429	358	312	247	252	232	173	170	238	207	297
Total Preferred & Common Equity	429	358	312	247	252	229	170	168	235	204	294
Total Common Equity	429	358	312	247	252	229	170	168	235	204	294
Common Stock	720	732	770	770	791	875	931	951	1,080	1,093	1,296
Retained Earnings	-292	-374	-458	-523	-539	-645	-761	-784	-845	-889	-943
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-58
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-0.02	-0.01	-0.05	0.02	-0.04	-0.18	-0.39	-0.66
Noncontrolling Interest	-	-	-	-	-	2.83	2.75	2.65	2.64	2.90	2.85

This table displays calculated financial ratios and metrics derived from Enovix's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	1/2/2022	1/1/2023	12/31/2023	12/29/2024	12/28/2025
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	23.25%	201.86%	37.91%
EBITDA Growth	0.00%	-218.78%	60.65%	-289.46%	3.08%	43.10%
EBIT Growth	0.00%	-217.94%	54.78%	-294.67%	-2.27%	34.93%
NOPAT Growth	0.00%	-195.46%	-89.84%	-74.46%	-5.39%	26.96%
Net Income Growth	0.00%	-217.46%	58.99%	-314.81%	-3.92%	29.63%
EPS Growth	0.00%	-118.37%	23.36%	-68.29%	7.97%	36.97%
Operating Cash Flow Growth	0.00%	-155.89%	-61.27%	-26.46%	-3.82%	12.28%
Free Cash Flow Firm Growth	0.00%	0.00%	-1,152.90%	-38.77%	23.56%	22.30%
Invested Capital Growth	0.00%	-936.65%	156.74%	285.11%	20.50%	18.29%
Revenue Q/Q Growth	0.00%	0.00%	21.39%	463.72%	11.26%	5.11%
EBITDA Q/Q Growth	0.00%	0.00%	60.00%	-17.78%	4.91%	11.16%
EBIT Q/Q Growth	0.00%	0.00%	55.39%	-28.05%	10.18%	2.02%
NOPAT Q/Q Growth	0.00%	0.00%	-18.27%	-9.32%	11.09%	-5.65%
Net Income Q/Q Growth	0.00%	0.00%	58.71%	-29.56%	9.21%	1.52%
EPS Q/Q Growth	0.00%	0.00%	44.59%	-23.21%	13.01%	-8.70%
Operating Cash Flow Q/Q Growth	0.00%	-31.44%	-6.49%	-5.43%	9.40%	-13.11%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-37.84%	32.86%	-5.11%
Invested Capital Q/Q Growth	0.00%	0.00%	261.97%	168.18%	4.13%	3.93%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	-274.70%	-724.97%	-8.86%	19.19%
EBITDA Margin	0.00%	0.00%	-788.15%	-2,490.45%	-799.64%	-329.93%
Operating Margin	0.00%	0.00%	-2,128.01%	-3,012.23%	-1,051.70%	-557.03%
EBIT Margin	0.00%	0.00%	-916.69%	-2,935.36%	-994.50%	-469.25%
Profit (Net Income) Margin	0.00%	0.00%	-832.34%	-2,801.31%	-964.44%	-492.15%
Tax Burden Percent	100.00%	100.00%	100.00%	99.71%	99.38%	99.17%
Interest Burden Percent	100.27%	100.12%	90.80%	95.72%	97.58%	105.76%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	-197.91%	-119.16%	-72.97%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	-174.62%	-72.43%	-37.48%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	128.56%	31.98%	13.13%
Return on Equity (ROE)	-109.48%	-69.48%	-15.13%	-69.35%	-87.18%	-59.84%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-551.40%	-315.45%	-137.75%	-89.72%
Operating Return on Assets (OROA)	0.00%	0.00%	-12.32%	-44.66%	-42.05%	-21.24%
Return on Assets (ROA)	0.00%	0.00%	-11.18%	-42.62%	-40.78%	-22.27%
Return on Common Equity (ROCE)	-109.48%	-69.48%	-15.13%	-69.02%	-86.22%	-59.22%
Return on Equity Simple (ROE_SIMPLE)	-109.48%	-38.60%	-14.48%	-82.95%	-90.19%	0.00%
Net Operating Profit after Tax (NOPAT)	-16	-49	-92	-161	-170	-124
NOPAT Margin	0.00%	0.00%	-1,489.61%	-2,108.56%	-736.19%	-389.92%
Net Nonoperating Expense Percent (NNEP)	-79.54%	-37.26%	11.51%	-23.29%	-46.73%	-35.49%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-25.92%	-36.96%	-39.63%	-15.45%
Cost of Revenue to Revenue	0.00%	0.00%	374.70%	824.97%	108.86%	80.81%
SG&A Expenses to Revenue	0.00%	0.00%	837.96%	1,033.67%	322.06%	229.50%
R&D to Revenue	0.00%	0.00%	936.00%	1,156.36%	539.59%	346.72%
Operating Expenses to Revenue	0.00%	0.00%	1,853.31%	2,287.26%	1,042.84%	576.22%
Earnings before Interest and Taxes (EBIT)	-40	-126	-57	-224	-229	-149
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-39	-124	-49	-190	-185	-105
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	5.52	12.15	5.48	8.14	8.14	6.07
Price to Tangible Book Value (P/TBV)	5.52	12.15	5.48	10.30	10.13	7.24
Price to Revenue (P/Rev)	0.00	0.00	315.12	274.79	87.01	51.75
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	24.16	0.00	48.59	15.25	12.30	8.46
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	263.06	257.94	83.07	49.02
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	203.43	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.67	0.72	1.93
Long-Term Debt to Equity	0.00	0.00	0.00	0.65	0.68	1.90
Financial Leverage	-0.80	-1.14	-1.04	-0.74	-0.44	-0.35
Leverage Ratio	1.79	1.51	1.35	1.63	2.14	2.69
Compound Leverage Factor	1.80	1.51	1.23	1.56	2.09	2.84
Debt to Total Capital	0.00%	0.00%	0.00%	40.13%	41.82%	65.88%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	1.36%	2.20%	1.23%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	38.77%	39.62%	64.65%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.68%	0.62%	0.35%
Common Equity to Total Capital	100.00%	100.00%	100.00%	59.19%	57.56%	33.77%
Debt to EBITDA	0.00	0.00	0.00	-0.92	-0.97	-5.04
Net Debt to EBITDA	0.00	0.00	0.00	0.69	0.51	0.85
Long-Term Debt to EBITDA	0.00	0.00	0.00	-0.89	-0.92	-4.95
Debt to NOPAT	0.00	0.00	0.00	-1.09	-1.06	-4.26
Net Debt to NOPAT	0.00	0.00	0.00	0.82	0.55	0.72
Long-Term Debt to NOPAT	0.00	0.00	0.00	-1.05	-1.00	-4.19
Altman Z-Score	-1.89	14.31	13.13	1.93	1.31	0.20
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.48%	1.10%	1.04%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	3.04	19.29	14.31	5.30	5.49	8.34
Quick Ratio	2.68	18.67	14.03	5.07	5.17	8.01
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	18	-185	-257	-196	-153
Operating Cash Flow to CapEx	-74.39%	-117.72%	-228.49%	-169.33%	-142.59%	-522.92%
Free Cash Flow to Firm to Interest Expense	0.00	94.03	0.00	-57.65	-28.93	-7.06
Operating Cash Flow to Interest Expense	-187.38	-274.36	0.00	-23.48	-16.01	-4.41
Operating Cash Flow Less CapEx to Interest Expense	-439.28	-507.43	0.00	-37.35	-27.23	-5.26
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.01	0.02	0.04	0.05
Accounts Receivable Turnover	0.00	0.00	0.00	14.17	8.43	7.08
Inventory Turnover	0.00	0.00	0.00	13.46	3.06	2.42
Fixed Asset Turnover	0.00	0.00	0.07	0.06	0.14	0.19
Accounts Payable Turnover	1.62	0.75	4.55	4.45	1.63	1.88
Days Sales Outstanding (DSO)	0.00	0.00	0.00	25.76	43.30	51.54
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	27.12	119.16	151.03
Days Payable Outstanding (DPO)	225.27	484.97	80.27	81.98	223.36	193.81
Cash Conversion Cycle (CCC)	0.00	0.00	-80.27	-29.10	-60.90	8.76
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	7.07	-59	34	129	156	184
Invested Capital Turnover	0.00	0.00	-0.48	0.09	0.16	0.19
Increase / (Decrease) in Invested Capital	0.00	-66	93	96	27	28
Enterprise Value (EV)	171	3,577	1,632	1,972	1,917	1,560
Market Capitalization	200	3,962	1,954	2,101	2,008	1,647
Book Value per Share	$0.45	$2.25	$2.27	$1.54	$1.39	$1.26
Tangible Book Value per Share	$0.45	$2.25	$2.27	$1.22	$1.11	$1.05
Total Capital	36	326	356	436	429	803
Total Debt	0.00	0.00	0.00	175	179	529
Total Long-Term Debt	0.00	0.00	0.00	169	170	519
Net Debt	-29	-385	-323	-132	-94	-90
Capital Expenditures (CapEx)	27	44	36	62	76	18
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-6.97	-7.81	-16	-39	-22	-25
Debt-free Net Working Capital (DFNWC)	22	377	307	268	251	487
Net Working Capital (NWC)	22	377	307	262	241	477
Net Nonoperating Expense (NNE)	23	77	-41	53	53	33
Net Nonoperating Obligations (NNO)	-29	-385	-323	-132	-94	-90
Total Depreciation and Amortization (D&A)	0.58	1.52	7.97	34	45	44
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	-261.72%	-506.79%	-95.83%	-78.50%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	4,943.87%	3,507.01%	1,086.75%	1,530.62%
Net Working Capital to Revenue	0.00%	0.00%	4,943.87%	3,429.60%	1,045.79%	1,499.62%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($1.07)	($0.34)	($1.35)	($1.27)	($0.75)
Adjusted Weighted Average Basic Shares Outstanding	0.00	156.48M	152.92M	159.07M	175.04M	207.64M
Adjusted Diluted Earnings per Share	$0.00	($1.07)	($0.82)	($1.38)	($1.27)	($0.75)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	156.48M	154.15M	159.58M	175.04M	207.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	($1.07)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	117.22M	157.78M	168.50M	191.27M	217.22M
Normalized Net Operating Profit after Tax (NOPAT)	-16	-49	-89	-156	-141	-124
Normalized NOPAT Margin	0.00%	0.00%	-1,434.06%	-2,040.50%	-609.36%	-389.92%
Pre Tax Income Margin	0.00%	0.00%	-832.34%	-2,809.59%	-970.47%	-496.27%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-369.56	-672.32	0.00	-50.35	-33.81	-6.91
NOPAT to Interest Expense	-153.93	-260.24	0.00	-36.17	-25.03	-5.75
EBIT Less CapEx to Interest Expense	-621.46	-905.39	0.00	-64.22	-45.04	-7.76
NOPAT Less CapEx to Interest Expense	-405.83	-493.31	0.00	-50.04	-36.25	-6.59
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-24.95%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-24.98%	-0.02%	-0.01%	0.00%	-41.80%

This table displays calculated financial ratios and metrics derived from Enovix's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/29/2024	3/30/2025	6/29/2025	9/28/2025	12/28/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-99.18%	2,400.00%	575.30%	25,004.76%	8,871.43%	2,058.50%	31.65%	-3.30%	98.20%	85.08%	15.93%
EBITDA Growth	-15,114.56%	80.12%	-275.50%	67.47%	-85.41%	6.04%	24.35%	32.29%	68.15%	-135.78%	13.39%
EBIT Growth	-3,652.04%	77.37%	-350.80%	36.18%	-84.58%	-13.88%	41.16%	49.72%	62.47%	-108.32%	8.27%
NOPAT Growth	-84.96%	-49.60%	-43.46%	-10.89%	-71.18%	2.22%	46.72%	39.32%	50.72%	4.66%	-27.44%
Net Income Growth	-5,565.73%	80.27%	-436.96%	36.83%	-80.31%	-39.87%	37.62%	49.39%	61.82%	-137.52%	6.44%
EPS Growth	-127.78%	45.28%	-520.00%	40.43%	-63.41%	-3.45%	90.48%	57.14%	65.08%	3.57%	0.00%
Operating Cash Flow Growth	-14.27%	-37.09%	-24.69%	-36.83%	-14.42%	-8.63%	41.39%	51.75%	4.04%	16.80%	-69.19%
Free Cash Flow Firm Growth	109.49%	-54.95%	-13.44%	-256.14%	-5,664.75%	-83.13%	64.09%	70.38%	30.53%	55.42%	-17.03%
Invested Capital Growth	-88.99%	419.79%	285.11%	697.79%	2,018.12%	210.33%	20.50%	15.50%	78.41%	18.52%	18.29%
Revenue Q/Q Growth	100.00%	376.19%	3,590.50%	-28.57%	-28.53%	14.57%	125.09%	-47.54%	46.49%	6.99%	40.99%
EBITDA Q/Q Growth	13.50%	74.39%	-143.93%	39.80%	-392.98%	87.02%	-96.38%	46.11%	-131.91%	3.92%	27.86%
EBIT Q/Q Growth	12.99%	71.36%	-233.28%	23.14%	-151.63%	82.33%	-72.19%	34.32%	-87.82%	1.93%	24.18%
NOPAT Q/Q Growth	18.03%	2.82%	-28.57%	-8.27%	-26.54%	44.49%	29.94%	-23.31%	-2.76%	-7.41%	6.35%
Net Income Q/Q Growth	12.63%	74.83%	-270.95%	22.55%	-149.36%	80.48%	-65.44%	37.17%	-88.12%	-21.47%	34.83%
EPS Q/Q Growth	12.77%	29.27%	27.59%	-33.33%	-139.29%	55.22%	93.33%	-500.00%	-83.33%	-22.73%	48.15%
Operating Cash Flow Q/Q Growth	8.04%	-19.93%	3.60%	-28.71%	23.10%	-13.85%	47.99%	-5.95%	-52.95%	1.29%	-5.77%
Free Cash Flow Firm Q/Q Growth	105.77%	-2,682.50%	-90.10%	-25.62%	9.77%	15.01%	62.72%	-3.62%	-111.59%	45.46%	2.14%
Invested Capital Q/Q Growth	-73.61%	895.17%	168.18%	13.28%	-29.94%	45.80%	4.13%	8.58%	8.22%	-3.14%	3.93%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	-33,792.86%	-8,304.50%	-167.84%	-34.14%	-17.38%	-14.87%	10.83%	5.12%	26.00%	17.53%	22.20%
EBITDA Margin	-149,247.62%	-8,027.00%	-530.57%	-447.19%	-3,084.53%	-349.43%	-304.87%	-313.12%	-495.72%	-445.16%	-227.76%
Operating Margin	-123,440.48%	-25,191.50%	-877.62%	-1,330.35%	-2,355.36%	-1,141.23%	-355.21%	-834.84%	-585.61%	-587.90%	-390.48%
EBIT Margin	-157,585.71%	-9,477.00%	-855.85%	-920.90%	-3,242.25%	-500.00%	-382.50%	-478.83%	-613.94%	-562.78%	-302.65%
Profit (Net Income) Margin	-153,109.52%	-8,092.50%	-813.41%	-881.96%	-3,077.15%	-524.39%	-385.43%	-461.57%	-592.74%	-672.95%	-311.06%
Tax Burden Percent	100.00%	100.00%	98.96%	99.67%	96.20%	110.73%	103.17%	99.32%	98.09%	99.22%	100.38%
Interest Burden Percent	97.16%	85.39%	96.04%	96.08%	98.66%	94.71%	97.66%	97.06%	98.43%	120.52%	102.39%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-4,117.46%	-831.83%	-57.66%	-145.70%	-509.99%	-167.47%	-40.25%	-84.79%	-76.33%	-76.21%	-51.15%
ROIC Less NNEP Spread (ROIC-NNEP)	-4,108.53%	-838.73%	-51.20%	-147.07%	-475.59%	-178.01%	-28.45%	-92.91%	-47.28%	-46.45%	-46.51%
Return on Net Nonoperating Assets (RNNOA)	3,811.61%	759.78%	37.69%	102.53%	354.00%	94.70%	12.56%	30.50%	11.71%	13.95%	16.29%
Return on Equity (ROE)	-305.85%	-72.05%	-19.97%	-43.18%	-156.00%	-72.78%	-27.68%	-54.30%	-64.62%	-62.25%	-34.86%
Cash Return on Invested Capital (CROIC)	-395.39%	-648.38%	-315.45%	-356.86%	-538.97%	-295.65%	-137.75%	-109.78%	-139.66%	-88.79%	-89.72%
Operating Return on Assets (OROA)	-357.49%	-26.03%	-13.02%	-25.83%	-104.85%	-21.42%	-16.17%	-21.76%	-34.09%	-25.02%	-13.70%
Return on Assets (ROA)	-347.34%	-22.22%	-12.37%	-24.74%	-99.51%	-22.47%	-16.30%	-20.97%	-32.91%	-29.92%	-14.08%
Return on Common Equity (ROCE)	-305.85%	-72.05%	-19.87%	-42.95%	-154.97%	-72.32%	-27.38%	-53.66%	-63.66%	-61.52%	-34.50%
Return on Equity Simple (ROE_SIMPLE)	-93.46%	-65.46%	0.00%	-81.57%	-140.14%	-146.26%	0.00%	-84.87%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-36	-35	-45	-49	-62	-34	-24	-30	-31	-33	-31
NOPAT Margin	-86,408.33%	-17,634.05%	-614.33%	-931.24%	-1,648.75%	-798.86%	-248.65%	-584.39%	-409.92%	-411.53%	-273.34%
Net Nonoperating Expense Percent (NNEP)	-8.93%	6.90%	-6.46%	1.37%	-34.40%	10.54%	-11.79%	8.12%	-29.05%	-29.76%	-4.64%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-10.40%	-12.01%	-	-	-5.64%	-7.14%	-7.92%	-3.98%	-3.83%
Cost of Revenue to Revenue	33,892.86%	8,404.50%	267.84%	134.14%	117.38%	114.87%	89.17%	94.88%	74.00%	82.47%	77.80%
SG&A Expenses to Revenue	39,733.33%	8,622.50%	241.25%	370.79%	554.25%	480.52%	135.18%	331.35%	234.69%	252.74%	163.47%
R&D to Revenue	39,411.90%	6,754.00%	468.53%	925.42%	771.36%	561.04%	230.86%	508.61%	376.91%	352.69%	249.21%
Operating Expenses to Revenue	89,647.62%	16,887.00%	709.78%	1,296.21%	2,337.98%	1,126.36%	366.04%	839.96%	611.61%	605.43%	412.69%
Earnings before Interest and Taxes (EBIT)	-66	-19	-63	-49	-122	-22	-37	-24	-46	-45	-34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-63	-16	-39	-24	-116	-15	-30	-16	-37	-36	-26
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	11.54	7.96	8.14	5.89	15.43	10.04	8.14	6.08	9.32	6.74	6.07
Price to Tangible Book Value (P/TBV)	11.54	7.96	10.30	7.62	22.03	14.28	10.13	7.62	12.06	7.96	7.24
Price to Revenue (P/Rev)	2,451.21	1,482.00	274.79	104.67	158.13	81.14	87.01	62.48	71.39	65.53	51.75
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	538.86	37.44	15.25	8.65	24.95	11.13	12.30	8.07	10.26	10.53	8.46
Enterprise Value to Revenue (EV/Rev)	2,242.93	1,331.37	257.94	98.25	154.05	80.27	83.07	59.60	70.61	61.66	49.02
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.67	0.66	0.67	0.76	1.04	1.06	0.72	0.76	0.87	1.78	1.93
Long-Term Debt to Equity	0.67	0.66	0.65	0.73	0.97	0.99	0.68	0.71	0.82	1.74	1.90
Financial Leverage	-0.93	-0.91	-0.74	-0.70	-0.74	-0.53	-0.44	-0.33	-0.25	-0.30	-0.35
Leverage Ratio	1.52	1.62	1.63	1.69	2.45	2.29	2.14	2.15	2.52	2.91	2.69
Compound Leverage Factor	1.47	1.38	1.56	1.62	2.41	2.17	2.09	2.08	2.48	3.51	2.75
Debt to Total Capital	40.28%	39.82%	40.13%	43.23%	50.91%	51.43%	41.82%	43.02%	46.53%	64.01%	65.88%
Short-Term Debt to Total Capital	0.00%	0.00%	1.36%	2.08%	3.12%	3.30%	2.20%	2.48%	2.69%	1.23%	1.23%
Long-Term Debt to Total Capital	40.28%	39.82%	38.77%	41.16%	47.79%	48.14%	39.62%	40.54%	43.84%	62.78%	64.65%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.68%	0.69%	0.78%	0.76%	0.62%	0.63%	0.75%	0.34%	0.35%
Common Equity to Total Capital	59.72%	60.18%	59.19%	56.08%	48.31%	47.81%	57.56%	56.34%	52.72%	35.64%	33.77%
Debt to EBITDA	-0.74	-1.03	-0.92	-1.25	-0.92	-0.93	-0.97	-1.02	-1.84	-4.47	-5.04
Net Debt to EBITDA	1.07	1.26	0.69	0.61	0.36	0.11	0.51	0.39	0.24	1.01	0.85
Long-Term Debt to EBITDA	-0.74	-1.03	-0.89	-1.19	-0.86	-0.87	-0.92	-0.96	-1.73	-4.39	-4.95
Debt to NOPAT	-1.23	-1.13	-1.09	-1.06	-0.94	-0.94	-1.06	-1.19	-1.51	-4.50	-4.26
Net Debt to NOPAT	1.79	1.39	0.82	0.52	0.37	0.11	0.55	0.46	0.20	1.02	0.72
Long-Term Debt to NOPAT	-1.23	-1.13	-1.05	-1.01	-0.88	-0.88	-1.00	-1.12	-1.42	-4.41	-4.19
Altman Z-Score	4.95	3.70	2.87	1.38	2.52	1.51	2.52	1.31	1.87	1.05	0.64
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.48%	0.52%	0.65%	0.63%	1.10%	1.16%	1.49%	1.18%	1.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	11.07	8.52	5.30	4.89	3.98	3.77	5.49	4.68	4.37	9.72	8.34
Quick Ratio	10.95	8.42	5.07	4.65	3.71	3.41	5.17	4.37	3.99	9.34	8.01
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2.87	-74	-141	-177	-160	-136	-51	-52	-111	-61	-59
Operating Cash Flow to CapEx	-185.57%	-163.69%	-94.49%	-232.26%	-106.90%	-157.08%	-97.55%	-269.56%	-324.41%	-858.59%	-2,681.13%
Free Cash Flow to Firm to Interest Expense	2.26	-47.66	-86.60	-106.82	-94.56	-79.10	-29.47	-30.59	-65.15	-5.15	-9.25
Operating Cash Flow to Interest Expense	-18.54	-18.14	-16.71	-21.12	-15.94	-17.86	-9.28	-9.85	-15.17	-2.17	-4.21
Operating Cash Flow Less CapEx to Interest Expense	-28.54	-29.22	-34.40	-30.22	-30.84	-29.23	-18.80	-13.51	-19.84	-2.42	-4.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.02	0.03	0.03	0.04	0.04	0.05	0.06	0.04	0.05
Accounts Receivable Turnover	16.17	387.43	14.17	14.75	19.47	21.69	8.43	9.90	9.00	9.26	7.08
Inventory Turnover	59.34	160.86	13.46	15.75	9.33	7.41	3.06	2.69	2.10	2.07	2.42
Fixed Asset Turnover	0.01	0.01	0.06	0.10	0.12	0.14	0.14	0.14	0.16	0.18	0.19
Accounts Payable Turnover	4.46	4.28	4.45	4.82	2.93	2.17	1.63	1.15	1.44	1.41	1.88
Days Sales Outstanding (DSO)	22.58	0.94	25.76	24.75	18.74	16.83	43.30	36.86	40.54	39.44	51.54
Days Inventory Outstanding (DIO)	6.15	2.27	27.12	23.18	39.12	49.27	119.16	135.73	174.18	176.59	151.03
Days Payable Outstanding (DPO)	81.76	85.34	81.98	75.76	124.41	167.86	223.36	318.10	253.64	259.01	193.81
Cash Conversion Cycle (CCC)	-53.03	-82.13	-29.10	-27.83	-66.55	-101.77	-60.90	-145.51	-38.92	-42.98	8.76
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4.85	48	129	146	103	150	156	169	183	177	184
Invested Capital Turnover	0.05	0.05	0.09	0.16	0.31	0.21	0.16	0.15	0.19	0.19	0.19
Increase / (Decrease) in Invested Capital	-39	39	96	128	98	101	27	23	80	28	28
Enterprise Value (EV)	2,611	1,805	1,972	1,267	2,561	1,665	1,917	1,365	1,878	1,867	1,560
Market Capitalization	2,853	2,010	2,101	1,350	2,628	1,683	2,008	1,431	1,899	1,984	1,647
Book Value per Share	$1.56	$1.58	$1.54	$1.36	$1.00	$0.95	$1.39	$1.23	$1.06	$1.50	$1.26
Tangible Book Value per Share	$1.56	$1.58	$1.22	$1.05	$0.70	$0.67	$1.11	$0.98	$0.82	$1.27	$1.05
Total Capital	414	420	436	409	353	351	429	417	387	826	803
Total Debt	167	167	175	177	179	180	179	180	180	528	529
Total Long-Term Debt	167	167	169	168	169	169	170	169	169	518	519
Net Debt	-242	-204	-132	-86	-70	-21	-94	-69	-24	-120	-90
Capital Expenditures (CapEx)	13	17	29	15	25	20	16	6.27	7.97	2.97	1.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-33	-40	-39	-33	-37	-25	-22	-25	-17	-21	-25
Debt-free Net Working Capital (DFNWC)	376	332	268	230	213	176	251	223	186	538	487
Net Working Capital (NWC)	376	332	262	221	202	165	241	212	176	528	477
Net Nonoperating Expense (NNE)	28	-19	15	-2.60	54	-12	13	-6.26	14	21	4.25
Net Nonoperating Obligations (NNO)	-242	-204	-132	-86	-70	-21	-94	-69	-24	-120	-90
Total Depreciation and Amortization (D&A)	3.50	2.90	24	25	5.94	6.50	7.54	8.45	8.83	9.40	8.44
Debt-free, Cash-free Net Working Capital to Revenue	-2,818.99%	-2,929.79%	-506.79%	-254.21%	-221.97%	-119.74%	-95.83%	-110.94%	-63.68%	-68.08%	-78.50%
Debt-free Net Working Capital to Revenue	32,339.43%	24,455.09%	3,507.01%	1,780.63%	1,281.72%	849.07%	1,086.75%	972.71%	701.02%	1,777.85%	1,530.62%
Net Working Capital to Revenue	32,339.43%	24,455.09%	3,429.60%	1,714.80%	1,215.61%	793.35%	1,045.79%	927.44%	661.90%	1,744.32%	1,499.62%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.41)	($0.10)	($0.37)	($0.28)	($0.67)	($0.13)	($0.19)	($0.12)	($0.22)	($0.26)	($0.15)
Adjusted Weighted Average Basic Shares Outstanding	157.15M	159.83M	159.07M	168.14M	172.40M	176.68M	175.04M	191.30M	204.82M	206.46M	207.64M
Adjusted Diluted Earnings per Share	($0.41)	($0.29)	($0.21)	($0.28)	($0.67)	($0.30)	($0.02)	($0.12)	($0.22)	($0.27)	($0.14)
Adjusted Weighted Average Diluted Shares Outstanding	157.15M	161.37M	159.58M	168.14M	172.40M	176.87M	175.04M	191.30M	204.82M	206.81M	207.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	320.25M	167.77M	168.50M	170.00M	176.28M	177.98M	191.27M	192.00M	196.60M	215.82M	217.22M
Normalized Net Operating Profit after Tax (NOPAT)	-33	-33	-45	-49	-35	-32	-24	-30	-31	-33	-31
Normalized NOPAT Margin	-79,056.67%	-16,576.70%	-614.33%	-931.24%	-940.10%	-739.50%	-248.65%	-584.39%	-409.92%	-411.53%	-273.34%
Pre Tax Income Margin	-153,109.52%	-8,092.50%	-821.99%	-884.84%	-3,198.86%	-473.57%	-373.57%	-464.75%	-604.27%	-678.24%	-309.88%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-52.12	-12.17	-38.78	-29.26	-72.25	-12.56	-21.62	-14.23	-26.89	-3.82	-5.32
NOPAT to Interest Expense	-28.58	-22.65	-27.84	-29.59	-36.74	-20.07	-14.06	-17.36	-17.95	-2.79	-4.80
EBIT Less CapEx to Interest Expense	-62.11	-23.26	-56.47	-38.36	-87.15	-23.93	-31.14	-17.88	-31.57	-4.07	-5.48
NOPAT Less CapEx to Interest Expense	-38.57	-33.73	-45.52	-38.69	-51.65	-31.44	-23.57	-21.02	-22.63	-3.05	-4.96
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.01%	-0.01%	-0.01%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	-40.49%	-41.80%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from Enovix (ENVX) the last four years of quarterly results, focused on the latest four quarters in 2025 and the surrounding period. The company continues to burn cash and post quarterly losses, but there are signs of top-line growth and a liquidity boost from financing activity in 2025.

Q4 2025 Operating Revenue reached about $11.3 million, up from prior 2025 quarters, indicating a rising top line.
Q4 2025 Total Gross Profit was about $2.50 million, yielding a gross margin around 22%, an improvement versus earlier quarters in 2025.
Q3 2025 Financing activity provided a large inflow: Net cash from continuing financing activities was about $473.4 million, boosting liquidity.
Q3 2025 cash and cash equivalents stood at roughly $335.5 million, up from mid-2025 levels and improving near-term liquidity.
Balance sheet growth in 2025 shows total assets rising (e.g., $913.7 million at Q3 2025) driven in part by financing and asset base expansion, which can support operations and investments.
R&D and SG&A remain very high relative to revenue (Q4 2025: RD about $28.1 million, SG&A about $18.4 million), contributing to ongoing operating losses.
Debt and leverage rose in 2025 (e.g., Long-Term Debt around $518.3 million at Q3 2025), reflecting capital-raising activities to fund operations and investments.
Net income remains negative across the latest quarters (Q4 2025: about -$34.99 million attributable to common shareholders; Q3 2025: about -$53.71 million; Q2 2025: about -$44.53 million; Q1 2025: about -$23.51 million).
Operating cash flow is negative in every quarter shown (Q4 2025: net cash from continuing operating activities about -$27.0 million), signaling ongoing cash burn from core operations.
Investing cash outflows are substantial, with significant purchases of investments and other assets (e.g., Q3 2025 net cash from continuing investing activities about -$248.1 million; Q4 2025 about -$199.1 million), underscoring heavy capital deployment beyond ongoing operations.

05/05/26 08:42 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Enovix's Financials

When does Enovix's financial year end?

According to the most recent income statement we have on file, Enovix's fiscal year ends in December. Their fiscal year 2025 ended on December 28, 2025.

How has Enovix's net income changed over the last 5 years?

Enovix's net income appears to be on an upward trend, with a most recent value of -$156.61 million in 2025, rising from -$39.65 million in 2020. The previous period was -$222.53 million in 2024. Check out Enovix's forecast to explore projected trends and price targets.

What is Enovix's operating income?

Enovix's total operating income in 2025 was -$177.25 million, based on the following breakdown:

Total Gross Profit: $6.11 million
Total Operating Expenses: $183.36 million

How has Enovix's revenue changed over the last 5 years?

Over the last 5 years, Enovix's total revenue changed from $0.00 in 2020 to $31.82 million in 2025, a change of 3,182,100,000.0%.

How much debt does Enovix have?

Enovix's total liabilities were at $604.96 million at the end of 2025, a 117.8% increase from 2024, and a 2,004.4% increase since 2020.

How much cash does Enovix have?

In the past 5 years, Enovix's cash and equivalents has ranged from $29.14 million in 2020 to $385.29 million in 2021, and is currently $106.01 million as of their latest financial filing in 2025.

How has Enovix's book value per share changed over the last 5 years?

Over the last 5 years, Enovix's book value per share changed from 0.45 in 2020 to 1.26 in 2025, a change of 178.9%.

Related Companies

Financial statements for NASDAQ:ENVX last updated on 2/26/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Enovix (ENVX) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Enovix's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Enovix (ENVX) Financials

Annual Income Statements for Enovix

Quarterly Income Statements for Enovix

Annual Cash Flow Statements for Enovix

Quarterly Cash Flow Statements for Enovix

Annual Balance Sheets for Enovix

Quarterly Balance Sheets for Enovix

Annual Metrics And Ratios for Enovix

Quarterly Metrics And Ratios for Enovix

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Enovix's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools